...
首页> 外文期刊>Molecular and Cellular Endocrinology >Dominant negative activity of thyroid hormone receptor variant alpha2 and interaction with nuclear corepressors.
【24h】

Dominant negative activity of thyroid hormone receptor variant alpha2 and interaction with nuclear corepressors.

机译:甲状腺激素受体变体α2的主要负活性以及与核共抑制因子的相互作用。

获取原文
获取原文并翻译 | 示例

摘要

The splicing variant of the thyroid hormone receptor alpha (TRalpha) gene, TR variant alpha2 (TRv alpha2), lacks the second half of the ninth heptad, a domain thought to be important for heterodimerization with retinoid X receptors (RXRs). In transient transfection studies, TRv alpha2 exhibits weak dominant negative inhibition of TRalpha1-mediated transcription. In contrast, a TRv alpha2 mutant in which the ninth heptad was restored (alpha2 + 9H), exhibits very strong dominant negative activity. We have examined the role of nuclear corepressors (CoRs) in the dominant negative activity of TRv alpha2 and alpha2 + 9H. Glutathione S-transferase pull down experiments revealed that TRv alpha2 barely interacts with CoRs, whereas alpha2 + 9H interaction with CoRs is as strong as that of TRalpha1. A P160R CoR box mutation was introduced in the context of TRv alpha2 and alpha2 + 9H, which nearly abolishes the ability of these receptors to interact with CoRs. In transient transfection the dominant negative activity of TRv alpha2 was only marginally impaired by the P160R mutation. In contrast, alpha2 + 9H-P160R had approximately 66% less dominant negative activity than alpha2 + 9H. These results suggest that the weak dominant negative activity of TRv alpha2 is due in part to its lack of interaction with CoRs, and that restoration of the ninth heptad restores CoR interaction and strong dominant negative activity. Further, the data reveal aspects of the dominant negative action that are dependent on the orientation of the TRE.
机译:甲状腺激素受体α(TRalpha)基因的剪接变体TR变体α2(TRv alpha2),缺少第九个七肽的后半部分,该区域被认为对于与类维生素A X受体(RXR)异源二聚化很重要。在瞬时转染研究中,TRv alpha2对TRalpha1介导的转录表现出弱的显性负抑制作用。相反,第九个七肽被还原的TRv alpha2突变体(alpha2 + 9H)表现出非常强的显性负活性。我们已经检查了TRv alpha2和alpha2 + 9H的显性负活动中核corepressors(CoRs)的作用。谷胱甘肽S-转移酶下拉实验表明,TRv alpha2几乎不与CoRs相互作用,而与CoRs的alpha2 + 9H相互作用与TRalpha1一样强。在TRv alpha2和alpha2 + 9H的背景下引入了P160R CoR盒突变,这几乎消除了这些受体与CoR相互作用的能力。在瞬时转染中,TRv alpha2的显性负活性仅受到P160R突变的轻微损害。相反,α2+ 9H-P160R的负性负活性比α2+ 9H少66%。这些结果表明,TRv alpha2的弱显性负活性部分是由于其与CoRs缺乏相互作用所致,第九个七pt体的恢复可恢复CoR相互作用和强的显性负活性。此外,数据揭示了取决于TRE方向的主要负面作用方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号